KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants.
Authors
Kennedy, JoannaGoudie, David
Blair, Edward
Chandler, Kate
Joss, Shelagh
McKay, Victoria
Green, Andrew
Armstrong, Ruth
Lees, Melissa
Kamien, Benjamin
Hopper, Bruce
Tan, Tiong Yang
Yap, Patrick
Stark, Zornitza
Okamoto, Nobuhiko
Miyake, Noriko
Matsumoto, Naomichi
Macnamara, Ellen
Murphy, Jennifer L
McCormick, Elizabeth
Hakonarson, Hakon
Falk, Marni J
Li, Dong
Blackburn, Patrick
Klee, Eric
Babovic-Vuksanovic, Dusica
Schelley, Susan
Hudgins, Louanne
Kant, Sarina
Isidor, Bertrand
Cogne, Benjamin
Bradbury, Kimberley
Williams, Mark
Patel, Chirag
Heussler, Helen
Duff-Farrier, Celia
Lakeman, Phillis
Scurr, Ingrid
Kini, Usha
Elting, Mariet
Reijnders, Margot
Schuurs-Hoeijmakers, Janneke
Wafik, Mohamed
Blomhoff, Anne
Ruivenkamp, Claudia A L
Nibbeling, Esther
Dingemans, Alexander J M
Douine, Emilie D
Nelson, Stanley F
Arboleda, Valerie A
Newbury-Ecob, Ruth
Issue Date
2018-09-24Keywords
KAT6A syndrome; chromatin modifiers; intellectual disabilitygenetic diagnosis
phenotypic spectrum
INTELLECTUAL DISABILITIES
DEVELOPMENTAL DELAY
Metadata
Show full item recordJournal
Genetics in medicine : official journal of the American College of Medical GeneticsDOI
10.1038/s41436-018-0259-2PubMed ID
30245513Abstract
Purpose: Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. Within 2 years, the number of patients identified with pathogenic KAT6A variants has rapidly expanded and the full extent and variability of the clinical phenotype has not been reported. Methods: We obtained data for patients with KAT6A pathogenic variants through three sources: treating clinicians, an online family survey distributed through social media, and a literature review. Results: We identified 52 unreported cases, bringing the total number of published cases to 76. Our results expand the genotypic spectrum of pathogenic variants to include missense and splicing mutations. We functionally validated a pathogenic splice-site variant and identified a likely hotspot location for de novo missense variants. The majority of clinical features in KAT6A syndrome have highly variable penetrance. For core features such as intellectual disability, speech delay, microcephaly, cardiac anomalies, and gastrointestinal complications, genotype- phenotype correlations show that late-truncating pathogenic variants (exons 16-17) are significantly more prevalent. We highlight novel associations, including an increased risk of gastrointestinal obstruction. Conclusion: Our data expand the genotypic and phenotypic spectrum for individuals with genetic pathogenic variants in KAT6A and we outline appropriate clinical management.Item Type
ArticleLanguage
enEISSN
1530-0366ae974a485f413a2113503eed53cd6c53
10.1038/s41436-018-0259-2
Scopus Count
Collections
Related articles
- A KAT6A variant in a family with autosomal dominantly inherited microcephaly and developmental delay.
- Authors: Trinh J, Hüning I, Yüksel Z, Baalmann N, Imhoff S, Klein C, Rolfs A, Gillessen-Kaesbach G, Lohmann K
- Issue date: 2018 Sep
- Neuropsychological profile associated with KAT6A syndrome: Emergent genotype-phenotype trends.
- Authors: Ng R, Kalinousky AJ, Harris J
- Issue date: 2024 May 13
- Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.
- Authors: Tham E, Lindstrand A, Santani A, Malmgren H, Nesbitt A, Dubbs HA, Zackai EH, Parker MJ, Millan F, Rosenbaum K, Wilson GN, Nordgren A
- Issue date: 2015 Mar 5
- Speech and language development and genotype-phenotype correlation in 49 individuals with KAT6A syndrome.
- Authors: St John M, Amor DJ, Morgan AT
- Issue date: 2022 Dec
- Diagnosis of Arboleda-Tham syndrome by whole-exome sequencing in an Asian girl with severe developmental delay.
- Authors: Wang Q, Zhang Y, Li L, Yang N
- Issue date: 2024 May